RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

$3.18
+0.49 (+18.22%)
As of Mar 25, 10:06 PM ET ·
Financial Highlights (FY 2025)
Revenue
45.23M
Net Income
4.09M
Gross Margin
67.6%
Profit Margin
9.0%
Rev Growth
+6.6%
D/E Ratio
0.15
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 67.6% 67.6% 67.6%
Operating Margin 9.1% 9.9% 10.5%
Profit Margin 9.0% 8.6% 9.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 45.23M 44.79M 46.31M
Gross Profit 30.56M 30.27M 31.30M
Operating Income 4.12M 4.45M 4.88M
Net Income 4.09M 3.84M 4.53M
Gross Margin 67.6% 67.6% 67.6%
Operating Margin 9.1% 9.9% 10.5%
Profit Margin 9.0% 8.6% 9.8%
Rev Growth +6.6% +21.1% +6.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 30.54M 36.84M 29.36M
Total Equity 197.87M 202.66M 221.37M
D/E Ratio 0.15 0.18 0.13
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 6.09M 5.25M 5.80M
Free Cash Flow 2.47M 3.54M 3.43M